SEC Form 4/A · accession 0001179110-15-010551
KYTHERA BIOPHARMACEUTICALS INC · KYTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
John W Smither
Officer — Chief Financial Officer
Period of report
Jun 25, 2015
Accepted (ET)
Jun 30, 2015 · 7:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001436304
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 25, 2015 | S | 4,600 | $75.50 | D | 7,616 | I | See Footnote |
| Common Stock | holding | — | — | — | 15,584 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares held by the 1994 Smither Family Trust dated March 1, 1994 as amended March 23, 2006, John W. Smither and Noretha V. Smither, Trustees (the "1994 Smither Family Trust").
Remarks
This purpose of this amendment to the Form 4 filed June 25, 2015 is to correctly report that the 4,600 shares sold were owned indirectly by the 1994 Smither Family Trust and not held directly by John Smither, as indicated in the original Form 4.